GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals appoints Shanti Ekambaram as Independent Director

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 28 Jul 2026, 10:04 AM IST  ·  BSE ID: 893d847e-b7a9-4f9c-ad46-959632669ba0
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has chosen Shanti Ekambaram to join as an independent director, pending shareholder confirmation.
🤖 AI Summary
  • Torrent Pharmaceuticals appointed Shanti Ekambaram as Additional Independent Director.
  • Her tenure commences on July 30, 2026, for a three-year term.
  • The appointment requires subsequent approval from the company's shareholders.
  • Ekambaram is not related to any existing company director.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders.
👤
Who Is Affected
All shareholders of Torrent Pharmaceuticals will be affected by changes in board composition.
🔍
Management Signal
The appointment signals management's intent to strengthen board oversight and governance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Shareholder meeting announcement for director approval.
Upcoming board meeting minutes for director committee assignments.
Torrent Pharmaceuticals' next quarterly results disclosure.
LOW RISK This is a standard board appointment with no inherent risks disclosed in the filing.
💡 Investor Takeaway
Torrent Pharmaceuticals appointed Shanti Ekambaram as an Additional Independent Director for a three-year term starting July 30, 2026, subject to shareholder approval.
❓ Frequently Asked Questions
Who has been appointed as an Additional Independent Director at Torrent Pharmaceuticals?
Shanti Ekambaram has been appointed as an Additional Independent Director at Torrent Pharmaceuticals.
When does the appointment of Shanti Ekambaram as Independent Director take effect?
The appointment of Shanti Ekambaram as an Independent Director takes effect from July 30, 2026.
What is the term of appointment for Shanti Ekambaram as Independent Director at Torrent Pharmaceuticals?
Shanti Ekambaram has been appointed for a term of 3 consecutive years.
Is Shanti Ekambaram related to any other Director of Torrent Pharmaceuticals?
No, Shanti Ekambaram is not related to any other Director of the Company.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.